WASHINGTON TRUST Co Cuts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

WASHINGTON TRUST Co lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 44,778 shares of the medical equipment provider’s stock after selling 1,397 shares during the period. Intuitive Surgical accounts for approximately 0.8% of WASHINGTON TRUST Co’s holdings, making the stock its 27th biggest position. WASHINGTON TRUST Co’s holdings in Intuitive Surgical were worth $23,372,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ISRG. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $595.55 on Friday. The firm has a 50 day moving average price of $558.58 and a 200 day moving average price of $518.00. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market capitalization of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.